Evaluation of Adoption and Implementation of the Revised (2014) FIP Basel Statements in Hospital Pharmacy Practice in Nigeria
This cross-sectional study of 383 Nigerian hospital pharmacists reveals strong adherence to global standards in medicine procurement, safety, and education, but highlights significant gaps in clinical integration, research, documentation, and the use of technology and informatics.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
In the modern hospital, the role of the pharmacist has grown far beyond the simple act of counting pills and handing them over a counter. Today, the profession is shifting toward a model where the pharmacist acts as a guardian of patient safety, deeply involved in the entire journey of a medicine from the moment it is ordered to the moment it is taken by a patient. This evolution aims to prevent errors, ensure treatments work as intended, and improve the overall quality of care. To guide this global shift, the International Pharmaceutical Federation, a massive organization representing millions of pharmacists worldwide, established a set of standards known as the Basel Statements. These statements, revised in 2014, act as a universal checklist for what a hospital pharmacy should look like, covering everything from how medicines are bought and stored to how pharmacists work with doctors and monitor patients. While these standards are clear, the reality of putting them into practice varies greatly depending on where a hospital is located, the resources available, and the local culture. Understanding how well these global ideals are being met in specific regions is crucial for improving health outcomes everywhere.
In Nigeria, a team of researchers set out to see how closely the country's hospital pharmacies matched these international standards. They focused on the 2014 Revised Basel Statements, using them as a measuring stick to evaluate the daily work of hospital pharmacists across the nation. The study, conducted in late 2023, gathered information from 383 pharmacists working in various hospitals, ranging from smaller community facilities to large teaching hospitals. The researchers asked these professionals to assess their own involvement in key areas, such as buying medicines, checking prescriptions, educating patients, and managing medical waste. The goal was not just to see what was working well, but to identify exactly where the gaps were, so that specific improvements could be made to align local practice with global best practices.
The results revealed a picture of strong foundations in some areas but significant room for growth in others. The pharmacists in Nigeria demonstrated a high level of competence in the fundamental logistics of medicine management. Nearly all of them played a strong role in ensuring that the medicines they procured were of high quality, and the vast majority were responsible for the safe storage and proper dispensing of these drugs. They were also very active in the safety net of healthcare, with most participating in the review of prescriptions before they were filled and reporting adverse reactions when patients had negative experiences with medications. Furthermore, the study found that these pharmacists were highly accessible to other healthcare professionals and were actively educating both doctors and patients on how to use medicines correctly. This suggests that the core mission of keeping medicines safe and ensuring they are used wisely is well-established in Nigerian hospitals.
However, the study also highlighted areas where the practice had not yet fully caught up with the global standards. While the basics were covered, the deeper, more specialized aspects of clinical pharmacy were often missing or inconsistent. For instance, fewer than half of the pharmacists were involved in systems that track medicines to ensure they can be traced from the manufacturer to the patient. The use of technology and computer systems to manage pharmacy data was also limited, with less than half of the respondents reporting strong engagement in this area. Perhaps most notably, the involvement of pharmacists in research and the formal documentation of their clinical interventions was low. Only about a quarter of the pharmacists reported that their colleagues were regularly conducting research or auditing how medicines were used, and even fewer consistently wrote down the specific advice or changes they made to a patient's treatment plan.
The researchers also found that the integration of pharmacists into the broader medical team was uneven. While many pharmacists were available to talk to doctors, only a small fraction were fully embedded in multidisciplinary teams where they worked side-by-side with nurses and physicians to make daily care decisions. Similarly, the preparation of specialized and potentially dangerous medicines, such as those used for cancer treatment, was not being managed by many of the respondents, likely due to a lack of specialized equipment or training. The monitoring of patients after they received medication was also inconsistent; while some pharmacists checked on every patient daily, others only checked when specific criteria were met, rather than taking a proactive approach to catch problems early.
These findings suggest that while Nigerian hospital pharmacists have mastered the essential tasks of supply and safety, the next step in their professional evolution requires a shift toward more active clinical integration and documentation. The researchers concluded that to fully align with the global standards set by the Basel Statements, there needs to be a concerted effort to improve training, encourage the use of technology, and create policies that require pharmacists to document their work and participate in research. By addressing these specific gaps, the healthcare system can move from simply having medicines available to ensuring that every patient receives the highest quality of pharmaceutical care, tailored to their specific needs and supported by evidence-based practices.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.